chr11-102594759-T-A

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_004771.4(MMP20):​c.954-2A>T variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00215 in 1,550,600 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 26)
Exomes 𝑓: 0.0021 ( 4 hom. )

Consequence

MMP20
NM_004771.4 splice_acceptor, intron

Scores

5
1
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 4.96
Variant links:
Genes affected
MMP20 (HGNC:7167): (matrix metallopeptidase 20) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The protein encoded by this gene degrades amelogenin, the major protein component of dental enamel matrix, and thus thought to play a role in tooth enamel formation. A mutation in this gene, which alters the normal splice pattern and results in premature termination of the encoded protein, has been associated with amelogenesis imperfecta. This gene is part of a cluster of MMP genes located on chromosome 11q22.3. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PP5
Variant 11-102594759-T-A is Pathogenic according to our data. Variant chr11-102594759-T-A is described in ClinVar as [Pathogenic]. Clinvar id is 5428.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-102594759-T-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MMP20NM_004771.4 linkuse as main transcriptc.954-2A>T splice_acceptor_variant, intron_variant ENST00000260228.3 NP_004762.2 O60882

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MMP20ENST00000260228.3 linkuse as main transcriptc.954-2A>T splice_acceptor_variant, intron_variant 1 NM_004771.4 ENSP00000260228.2 O60882
MMP20ENST00000544938.1 linkuse as main transcriptn.593-2A>T splice_acceptor_variant, intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00221
AC:
236
AN:
106738
Hom.:
1
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000535
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00786
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000196
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00256
Gnomad OTH
AF:
0.00612
GnomAD3 exomes
AF:
0.00106
AC:
256
AN:
240710
Hom.:
0
AF XY:
0.000995
AC XY:
130
AN XY:
130690
show subpopulations
Gnomad AFR exome
AF:
0.000451
Gnomad AMR exome
AF:
0.000921
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000142
Gnomad NFE exome
AF:
0.00189
Gnomad OTH exome
AF:
0.00189
GnomAD4 exome
AF:
0.00215
AC:
3102
AN:
1443796
Hom.:
4
Cov.:
36
AF XY:
0.00210
AC XY:
1510
AN XY:
718284
show subpopulations
Gnomad4 AFR exome
AF:
0.000399
Gnomad4 AMR exome
AF:
0.00123
Gnomad4 ASJ exome
AF:
0.0000391
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000248
Gnomad4 NFE exome
AF:
0.00264
Gnomad4 OTH exome
AF:
0.00190
GnomAD4 genome
AF:
0.00221
AC:
236
AN:
106804
Hom.:
1
Cov.:
26
AF XY:
0.00205
AC XY:
103
AN XY:
50338
show subpopulations
Gnomad4 AFR
AF:
0.000533
Gnomad4 AMR
AF:
0.00784
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000196
Gnomad4 NFE
AF:
0.00256
Gnomad4 OTH
AF:
0.00606
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.00218
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00291
AC:
25
ExAC
AF:
0.00106
AC:
129

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Amelogenesis imperfecta hypomaturation type 2A2 Pathogenic:4
Pathogenic, criteria provided, single submitterresearchHudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for BiotechnologyNov 09, 2022ACMG codes:PVS1_VeryStrong, PM2_Supporting, PM3_Strong -
Pathogenic, no assertion criteria providedliterature onlyOMIMMar 01, 2005- -
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteSep 20, 2024Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with amelogenesis imperfecta, type IIA2 (MIM#612529). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0211 - Canonical splice site variant without proven consequence on splicing (no functional evidence available). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v3) <0.01 for a recessive condition (234 heterozygotes, 1 homozygote). (SP) 0505 - Abnormal splicing is predicted by in silico tools and affected nucleotide is highly conserved. (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic by multiple clinical laboratories in ClinVar, and as a VUS in one older entry. This variant has also been observed in homozygous and compound heterozygous individuals with amelogenesis imperfecta, including individuals compound heterozygous with c.103A>C (PMID: 15744043, 33600052, 37228816, 26502894). (SP) 1201- Heterozygous variant detected in trans with a second pathogenic heterozygous variant, NM_004771.3(MMP20):c.103A>C p.(Arg35=), in a recessive disease. (I) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Pathogenic, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaSep 05, 2024- -
not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingGeneDxJun 15, 2022Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31980526, 25525159, 15744043, 22243262, 28659819, 26502894, 21597265, 16246936, 26124219, 16838342, 32495503, 31589614, 33600052) -
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpMay 13, 2019This sequence change affects an acceptor splice site in intron 6 of the MMP20 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs140213840, ExAC 0.2%). This variant has been reported in several families and individuals affected with autosomal recessive pigmented hypomaturation amelogenesis imperfecta (PMID: 15744043, 22243262, 21597265, 26502894). ClinVar contains an entry for this variant (Variation ID: 5428). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MMP20 are known to be pathogenic (PMID: 18096894, 23625376). For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenSep 01, 2023MMP20: PVS1, PM3, PM2:Supporting -
MMP20-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 03, 2024The MMP20 c.954-2A>T variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant has been previously reported in the homozygous or compound heterozygous state in several individuals with autosomal recessive amelogenesis imperfecta (Kim et al. 2005. PubMed ID: 15744043; Chan et al. 2011. PubMed ID: 22243262; Wright et al. 2011. PubMed ID: 21597265; Gasse et al. 2013. PubMed ID: 23625376; Prasad et al. 2016. PubMed ID: 26502894; Wang et al. 2020. PubMed ID: 32495503). It has also been identified in a genome sequencing cohort and interpreted as likely pathogenic (Hou et al. 2020. PubMed ID: 31980526). This variant is reported in 0.19% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Variants that disrupt the consensus splice acceptor site in MMP20 are expected to be pathogenic. This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.31
D
BayesDel_noAF
Pathogenic
0.23
CADD
Pathogenic
32
DANN
Uncertain
0.99
Eigen
Pathogenic
1.0
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
0.98
D
GERP RS
5.4

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.94
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.52
Position offset: -14
DS_AL_spliceai
0.99
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs140213840; hg19: chr11-102465490; API